Max Robotics — Global Service Robot Directory + US Certification

About

Yuki Kohada is a pioneering urologic surgeon and researcher whose work centers on advancing robotic surgery and improving quality-of-life outcomes for prostate and kidney cancer patients. His major contributions lie in evaluating the safety and effectiveness of novel robotic platforms—most notably the hinotori™ Surgical Robot System, where his 2024 study demonstrated its real-world utility in urologic tumor surgeries. Kohada has also made significant strides in post-prostatectomy recovery, leading a pilot study on low-intensity extracorporeal shock wave therapy for penile rehabilitation and identifying predictors of long-term urinary incontinence and sexual function preservation. His research on the impact of preoperative testosterone levels and patients’ interest in sex on postoperative satisfaction has reshaped how clinicians approach personalized recovery plans. With over 30 citations across his most-cited works, Kohada’s influence is growing rapidly. He also introduced the centrality angle, a novel nephrometry score that simplifies tumor complexity assessment for partial nephrectomy. His work not only refines surgical technique but also prioritizes patients’ long-term well-being, making him a rising leader in robotic urologic oncology.